SPOTLIGHT -
Clinical Status and Optimal Use of Rituximab for B-Cell Lymphomas
The standard management of low-grade lymphoma remains controversial. Long-term follow-up studies of patients treated with conventional regimens have shown that currently available treatments are not curative.